| ITM OncoBeta GmbH forms subsidiary in Australia |
| Monday, 20 September 2010 11:08 | |
|
In August 2010 ITM OncoBeta GmbH has formed a wholly owned daughter company “Oncobeta Australia PTY, Ltd” with headquarters in Perth, Westaustralia. OncoBeta Australia is headed by Dr. Michael Hauck and will be responsible for all business development, regulatory affairs and customer relations in conjunction with the introduction of the ITM Rhenium-SCT in Australia. Australia is the region in the world with the highest incidence of skin cancer per capita.
|
News
ITG has received the Manufacturing License for Lu-177 n.c.a.As of December 2011, ITG Isotope Technologies Garching GmbH has successfully passed the audit of the GMP production of the...Read more... |
ITG Isotope Technologies Garching GmbH (Germany) announces broad collaboration with ANSTO (Australia) on radioisotopesGarching, Germany, June 3, 2011. ITG Isotope Technologies Garching GmbH (ITG), a specialist in the development and production of innovative...Read more... |
Helmholtz Zentrum München and ITM AG enter antibody dealAscenion has mediated a license agreement between the Helmholtz Zentrum München and ITM Isotopen Technologien München AG providing the company...Read more... |